Outcome and Patient Experiences After Transurethral Resection and Bipolar Enucleation of the Prostate - a Multi-center, Randomized Controlled Trial.
1 other identifier
interventional
120
1 country
2
Brief Summary
In this randomized controlled trial, we will evaluate if bipolar enucleation of the prostate (BEEP) is associated with better urinary voiding outcome than transurethral resection (TURP) in men with enlarged prostate referred to surgery. In addition we will investigate the association between symptom relief and the amount of removed tissue and if patients experience differ between the two methods. Finally, we will assess cost-effectiveness of BEEP compared to TURP. The main outcome for comparison of the two surgical methods is International Prostate Symptom Score (IPSS) assessed at 12-month follow-up. The primary outcome to assess patient experience is measured with the questionnaire Nordic Patients Experience Questionnaire (NORPEQ). Cost-effectiveness will be measured with incremental cost-effectiveness ratio (ICER).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2025
CompletedFirst Submitted
Initial submission to the registry
April 24, 2026
CompletedFirst Posted
Study publicly available on registry
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
May 1, 2026
April 1, 2026
3.2 years
April 24, 2026
April 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
International Prostate Symptom Score (IPSS)
The primary outcome is IPPS score. IPSS is recommended by the European Association of Urology to evaluate LUTS in men.
IPSS will be assessed at baseline and after 12-month follow-up.
Study Arms (2)
Men with intermediate sized prostate and voiding problems treated with TURP.
ACTIVE COMPARATORMen with intermediate sized prostate and voiding problems are randomized to two different treatment modalities.
Men with intermediate sized prostate treated with BEEP.
ACTIVE COMPARATORMen with intermediate sized prostate and voiding problems are randomized to two different treatment modalities.
Interventions
The study compares two surgical treatments for voiding problems in men with enlarged prostate.
Men with intermediate sized prostate and voiding problems are randomized to two different treatment modalities.
Eligibility Criteria
You may qualify if:
- Men with prostate sizes between 30mL and 80mL on ultrasound, referred to BPH surgery, detrusor pressure ≥ 20 cmH2O on urodynamic tests, valid informed consent.
You may not qualify if:
- Previous surgery for BPH, men aged above 80 years old, severe comorbidity (not suitable for surgery), cognitive impairment, prostate cancer (palliative surgery), prior pelvic radiation therapy, anticoagulation/antiplatelet therapy can't be stopped.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Innlandet Hospital Trust
Hamar, 2318, Norway
Akershus University Hospital
Lørenskog, Norway
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2026
First Posted
May 1, 2026
Study Start
September 25, 2025
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
May 1, 2026
Record last verified: 2026-04